STOCK TITAN

If You Invested in Delphx Cap Mkts (DPXCF)

Financial Services · Capital Markets · OTC Link
Looking for the live price? See the DPXCF quote & overview
$1,000 invested 1 Year Ago
$422
-57.8% total -62.3% CAGR
Bought on Aug 5, 2025 at $0.04
$1,000 invested 5 Years Ago
$43
-95.7% total -47.0% CAGR
Bought on Jul 8, 2021 at $0.41

What $1,000 or $10,000 in DPXCF Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jul 27, 2018
$1,000 $422 -58% $43 -96% $30 -97%
$10,000 $4,217 -58% $427 -96% $299 -97%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for DPXCF

$1,000 Investment Over Time

DPXCF vs S&P 500

Year-by-Year Returns

DPXCF annual performance
Year Start Price End Price Annual Return Cumulative
2018 $0.58 $0.25 -56.7% -56.7%
2019 $0.25 $0.13 -49.4% -78.1%
2020 $0.12 $0.11 -10.6% -81.6%
2021 $0.11 $0.36 +239.2% -37.7%
2022 $0.36 $0.09 -76.4% -85.3%
2023 $0.09 $0.13 +50.0% -77.9%
2024 $0.13 $0.07 -43.4% -87.5%
2025 $0.10 $0.04 -60.0% -93.3%
2026 $0.05 $0.02 -64.1% -97.0%

About Delphx Cap Mkts

Financial Services · OTC Link

DelphX Capital Markets Inc. (OTCQB: DPXCF), also referenced as DelphX, is a technology and financial services company in the investment banking and securities dealing space. According to its public disclosures, the company focuses on developing and distributing the next generation of structured financial products that combine fixed-income and cryptocurrency-related features.

DelphX operates through a special purpose vehicle, Quantem LLC, which enables broker-dealers to offer new private placement securities. These securities are designed for qualified institutional buyers and other institutional accounts that seek structured exposure to corporate credit and digital assets. The company’s activities place it at the intersection of traditional finance and the evolving crypto-asset sector.

Core Products and Structure

DelphX states that its proprietary securities include two primary instruments:

  • Collateralized Put Options (CPOs), which are described as providing secured protection against rating downgrades of underlying corporate bonds and/or losses in cryptocurrency holdings.
  • Collateralized Reference Notes (CRNs), which enable investors to assume a capped rating-downgrade and/or cryptocurrency-loss exposure on an underlying security or cryptocurrency in exchange for potential returns.

All CPOs and CRNs are represented as fully collateralized instruments, with collateral held in custody by U.S. Bank. DelphX also notes that these instruments are proprietary products created and owned by DelphX Capital Markets Inc.

Quantem Crypto Securities (QCS) Program

DelphX has described the development of a Quantem Crypto Securities (QCS) platform, presented as a fully collateralized hedging solution for digital-asset treasuries and other institutional participants. The company has highlighted QCS as a mechanism intended to mitigate volatility and protect Bitcoin or other crypto-asset treasury holdings through structured, collateralized contracts.

In its public updates, DelphX has reported marketing efforts around QCS and interest from market participants. For example, it has indicated that a U.S. primary dealer has been evaluating a potential proof-of-concept collaboration aimed at deploying QCS within an existing digital-asset infrastructure, and that multiple digital-asset treasuries have been conducting due diligence and scenario testing on the QCS hedge program. The company also notes that there can be no assurance such implementations or transactions will occur.

Letter of Intent and Crypto-Treasury Focus

DelphX has announced a non-binding letter of intent with Belgravia Hartford Capital Inc. relating to what it describes as the first anticipated commercial transaction of its Quantem Crypto Security. Under the letter of intent, Belgravia is expected to become the first corporate purchaser of a QCS collateralized put option designed to protect and preserve corporate Bitcoin treasury holdings, subject to definitive agreements, regulatory approvals, market conditions, and other customary conditions. The company emphasizes that the letter of intent is non-binding, except for certain standard provisions, and may be terminated by either party.

DelphX also reports that Belgravia is expected to provide advisory and structuring support for the anticipated QCS launch, including assistance with program documentation, compliance processes, and onboarding coordination with a designated placement agent.

Capital Markets Activity

DelphX is listed on the TSX Venture Exchange under the symbol DELX and trades on the OTCQB market under the symbol DPXCF. The company has frequently used non-brokered private placements as a source of capital. In multiple announcements, DelphX has described offerings of units consisting of common shares and common share purchase warrants, with stated intentions to use net proceeds for working capital, corporate overhead, or general corporate purposes.

These placements typically involve a subscription price per unit and warrants exercisable at specified prices for a defined term. Certain offerings have included participation by insiders, which DelphX has identified as related party transactions under applicable securities regulations. The company has also disclosed instances of warrant extensions, subject to TSX Venture Exchange acceptance, and has referenced reliance on exemptions from formal valuation and minority approval requirements where the fair market value of the securities involved did not exceed a specified percentage of its market capitalization.

Custody and Collateralization

In its descriptions, DelphX consistently emphasizes that its CPOs and CRNs are fully collateralized and that collateral is held in custody by U.S. Bank. This structure is presented as central to the design of both its fixed-income and crypto-linked products, as well as to the QCS hedging program. The company positions this full-collateralization approach as a key characteristic of its structured offerings.

Corporate Governance and Options

DelphX has reported the use of stock options as part of its compensation and incentive arrangements. The board of directors has approved grants of options to eligible participants under its stock option plan, with specified maturities and exercise prices. The company has also disclosed transitions in its Chief Financial Officer role, including the departure of one CFO to pursue another opportunity and the appointment of an individual who previously served in that role.

Regulatory and Risk Disclosures

In its news releases, DelphX notes that completion of its private placements and warrant amendments is subject to TSX Venture Exchange approval and that securities issued are subject to hold periods. The company also references regulatory frameworks such as Multilateral Instrument 61-101 and TSXV Policy 5.9 in connection with related party transactions.

With respect to its crypto-related activities, DelphX has highlighted that the crypto market is high risk and subject to significant volatility. It presents its QCS program as a fully collateralized hedging solution intended to address risk management needs in the digital-asset sector, while acknowledging that there can be no assurance that contemplated collaborations or implementations will be completed.

Business Context

Within the finance and insurance sector, and more specifically within investment banking and securities dealing, DelphX describes itself as focused on structured products that blend elements of corporate credit and cryptocurrency exposure. Its disclosures emphasize product design, collateralization, and capital markets activity rather than detailed financial metrics or geographic expansion. Investors reviewing DPXCF stock typically consider the company’s progress in commercializing its proprietary CPO, CRN, and QCS offerings, as well as its ability to secure institutional participation and regulatory approvals for its programs.

Market Cap
$0.0B
Current Price
$0.02
View full DPXCF overview

Frequently Asked Questions

Delphx Cap Mkts investment returns

How much would $1,000 invested in Delphx Cap Mkts be worth today?

If you invested $1,000 in Delphx Cap Mkts (DPXCF) 5 years ago on 2021-07-08, your investment would be worth $43 today, representing a -95.7% total return, growing at a compounded rate of -47.0% per year (CAGR).

Has Delphx Cap Mkts outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare DPXCF performance over available time periods.

What is Delphx Cap Mkts's average annual return?

The compound annual growth rate (CAGR) of DPXCF over the past 5 years is -47.0%, growing at a compounded rate each year. Individual years vary significantly — DPXCF's best recent year was 2021 (+239.2%) and worst was 2022 (-76.4%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.